EMEA-002153-PIP01-17-M01
Key facts
| Invented name |
|
| Active substance |
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/0058/2020
|
| PIP number |
EMEA-002153-PIP01-17-M01
|
| Pharmaceutical form(s) |
Inhalation powder, pre-dispensed
|
| Condition(s) / indication(s) |
Treatment of asthma
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
GlaxoSmithKline Trading Services Limited
Tel. +1 4388998201 |
| Decision type |
RPM: decision refers to a refusal on the application for modification of an agreed PIP
|